Read + Share
Amedeo Smart
Independent Medical Education
Giuliani J, Mantoan B, Bonetti A. Cost-effectiveness of programmed death ligand-1 (PD-L1) blockade in first-line for metastatic gastric/gastroesophageal junction cancer. Eur J Cancer 2022;175:193-195.PMID: 36137394
Email
LinkedIn
Facebook
Twitter
Privacy Policy